ALS is an incurable nervous system disease that causes the loss of muscle control. A research team at the University of ...

“We are disappointed in the outcome of the MERIDIAN study, especially on behalf of the ALS community who has been waiting for new treatments for this complex and unrelenting disease,” said ...

Performing a quality patient assessment is not limited to an ALS skill, but rather is an EMS skill in which all levels of providers need to be proficient. While ALS providers do obtain much more ...

The ALS Association this summer will host the second edition of its ALS Nexus, a conference bringing together researchers, healthcare professionals, advocates, patients, and caregivers in a quest to ...

The multiple ascending dose trial is expected to recruit 48 patients with ALS and administer up to four doses of placebo or AMX0114 per participant. Amylyx expects early cohort data to be ...

Medicare patients referred to a neurologist had to wait a median of 34 days before being seen, and nearly 1 in 5 patients waited more than 90 days, in 2018 and 2019, according to a study published ...

The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ALS ...

The US Centers for Disease Control and Prevention is urging hospitals to accelerate advanced testing of people they suspect may have bird flu. Its alert to doctors and hospitals follows a few rare ...

Dr. Olivier Blanchard and his team want to know if a drug already approved for overactive bladder could block the overactive cells that inevitably end up damaging the connection between the nerves and ...

Tearful nurses told an RCN briefing in central London of being powerless as patients spend hours slowly dying on a trolley in a busy corridor and finding a dead patient under a pile of coats.